<br>        DISEASE CHARACTERISTICS:<br><br>          -  Histologically or cytologically confirmed fallopian tube cancer, Muellerian mixed<br>             tumor, endometrial cancer, uterine sarcoma, ovarian cancer with sarcoma parts, or<br>             cervical cancer<br><br>               -  No ovarian epithelial cancer<br><br>        PATIENT CHARACTERISTICS:<br><br>        Age:<br><br>          -  18 and over<br><br>        Performance status:<br><br>          -  ECOG 0-2 OR<br><br>          -  Karnofsky 70-100%<br><br>        Life expectancy:<br><br>          -  At least 3 months<br><br>        Hematopoietic:<br><br>          -  Absolute neutrophil count at least 1,500/mm3<br><br>          -  Platelet count at least 100,000/mm3<br><br>          -  Hemoglobin greater than 10.0 g/dL<br><br>        Hepatic:<br><br>          -  Bilirubin no greater than 1.25 times upper limit of normal<br><br>        Renal:<br><br>          -  Glomerular filtration rate at least 60 mL/min<br><br>        Cardiovascular:<br><br>          -  No atrial or ventricular arrhythmias<br><br>          -  No congestive heart failure even if stabilized on medication<br><br>          -  No New York Heart Association class III or IV heart disease<br><br>          -  No myocardial infarction within the past 6 months<br><br>        Other:<br><br>          -  No pre-existing sensory or motor neuropathy grade 2 or greater<br><br>          -  No active infection<br><br>          -  No other serious medical condition that would preclude study<br><br>          -  Not pregnant<br><br>          -  Negative pregnancy test<br><br>          -  Fertile patients must use effective contraception<br><br>        PRIOR CONCURRENT THERAPY:<br><br>        Biologic therapy:<br><br>          -  At least 4 weeks since prior immunotherapy<br><br>        Chemotherapy:<br><br>          -  No more than 1 prior chemotherapy regimen for the malignancy<br><br>          -  No other concurrent chemotherapy<br><br>        Endocrine therapy:<br><br>          -  Prior hormonal therapy within the past 10 days allowed<br><br>          -  No concurrent hormonal therapy<br><br>        Radiotherapy:<br><br>          -  At least 6 weeks since prior radiotherapy to no more than 25% of bone marrow<br><br>        Surgery:<br><br>          -  Not specified<br><br>        Other:<br><br>          -  At least 30 days since prior experimental agents<br><br>          -  No other concurrent therapies that would preclude study<br><br>          -  No concurrent participation in another study<br>